Strata (SRTA) Co-CEO/CFO William Heyburn Receives Award; Shares Withheld

What Happened

• William A. Heyburn, Co-CEO, CFO and a director of Strata Critical Medical (SRTA), had 177,858 performance-based restricted stock units (PSUs) vest on 2026-09-24 (award/acquisition). To satisfy tax-withholding obligations related to the vesting, 98,356 shares were withheld by the issuer (disposed) at an indicated value of $5.27 per share, totaling $518,336. The award was granted previously (Aug 29, 2025) and certified as vested by the Compensation Committee.

Key Details

• Transaction date: 2026-09-24; Form 4 filed: 2026-09-25 (timely).
• Awarded/acquired: 177,858 shares (code A) at $0.00 (PSU vesting).
• Withheld/disposed: 98,356 shares (code F) at $5.27 for $518,336 (tax withholding).
• Footnotes: F1 — shares were issued upon certification that performance criteria were met for PSUs granted Aug 29, 2025. F2 — withheld shares were used to satisfy tax withholding on vesting.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timeliness: Filed the day after the vesting date (within SEC timing requirements).

Context

• This was not an open-market sale or purchase but the vesting of performance-based RSUs with an internal share-withholding to cover taxes — a common administrative step that does not necessarily signal a change in insider sentiment. Code A = award/grant; Code F = shares withheld for tax withholding.